Intratumoral microbiome promotes liver metastasis and dampens adjuvant imatinib treatment in gastrointestinal stromal tumor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intratumoral microbiome promotes liver metastasis and dampens adjuvant imatinib treatment in gastrointestinal stromal tumor

Published:2024-10 Issue: Volume:601 Page:217149
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Li Yanze,Zhang Ruizhi^ORCID,Fu Chengbo,Jiang Qi,Zhang Peng,Zhang Yong,Chen Jingchao,Tao Kaixiong,Chen Wei-Hua^ORCID,Zeng Xiangyu

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference42 articles.

1. Gastrointestinal stromal tumours: origin and molecular oncology;Corless;Nat. Rev. Cancer,2011

2. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors;Hirota;Science,1998

3. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial;Demetri;Lancet,2013

4. Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth;Ran;Cancer Discov.,2015

5. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors;Demetri;N. Engl. J. Med.,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP